Metabolic Factors Associated with Risk of Renal Cell Carcinoma

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Häggström, Christel ^a   Rapp, Kilian ^b   Stocks, Tanja ^a,c   Manjer, Jonas ^d   Bjørge, Tone ^e,f   Ulmer, Hanno ^g   Engeland, Anders ^e,f   Almqvist, Martin ^d   Concin, Hans ^h   Selmer, Randi ^f   Ljungberg, Börje ^a   Tretli, Steinar ⁱ   Nagel, Gabriele ^b,h   Hallmans, Göran ^a   Jonsson, Håkan ^a   Stattin, Pär ^a,j  

^a UMEÅ UNIVERSITY   (Sweden)

^b UNIVERSITY OF ULM   (Germany)

^c The Capital Region   (Denmark)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e UNIVERSITY OF BERGEN   (Norway)

^f NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^g INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^h AGENCY FOR PREVENTIVE AND SOCIAL MEDICINE   (Austria)

ⁱ Cancer Registry of Norway   (Norway)

^j MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CANCER INCIDENCE; CANCER RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 84874570151     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057475     Document Type: Article

References (38)

1. Weikert S, Ljungberg B, (2010) Contemporary epidemiology of renal cell carcinoma: perspectives of primary prevention. World J Urol 28: 247-252.
2. Chow WH, Dong LM, Devesa SS, (2010) Epidemiology and risk factors for kidney cancer. Nat Rev Urol 7: 245-257.
3. Chow W, Devesa S, Warren J, Fraumeni J Jr, (1999) Rising Incidence of Renal Cell Cancer in the United States. JAMA 281: 1628-1631.
4. Benichou J, Chow WH, McLaughlin JK, Mandel JS, Fraumeni JF Jr, (1998) Population attributable risk of renal cell cancer in Minnesota. Am J Epidemiol 148: 424-430.
5. Joh HK, Willett WC, Cho E, (2011) Type 2 diabetes and the risk of renal cell cancer in women. Diabetes care 34: 1552-1556.
6. Chow W, Gridley G, Fraumeni J, Jarvholm B, (2000) Obesity, Hypertension, and the Risk of Kidney Cancer in Men. N Engl J Med 343: 1305-1311.
7. Van Hemelrijck M, Garmo H, Hammar N, Jungner I, Walldius G, et al. (2011) The interplay between lipid profiles, glucose, BMI and risk of kidney cancer in the Swedish AMORIS study. Int J Cancer 130: 2118-28.
8. Kitahara CM, Berrington de Gonzalez A, Freedman ND, Huxley R, Mok Y, et al. (2011) Total cholesterol and cancer risk in a large prospective study in Korea. J Clin Oncol 29: 1592-1598.
9. Jee S, Ohrr H, Sull J, Yun J, Ji M, et al. (2005) Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293: 194-202.
10. Stocks T, Borena W, Strohmaier S, Bjorge T, Manjer J, et al. (2009) Cohort Profile: The Metabolic syndrome and Cancer project (Me-Can). Int J Epidemiol 39: 660-7.
11. Eurostat (1998) European shortlist for causes of death. Available: http://ec.europa.eu/eurostat/ramon/nomenclatures/index.cfm?TargetUrl=LST_NOM_DTL&StrNom=COD_1998&StrLanguageCode=EN&IntPcKey=&StrLayoutCode=HIERARCHIC. Accessed 2012 Apr 23.
12. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360: 1903-1913.
13. Bland JM, Altman DG, (1995) Multiple significance tests: the Bonferroni method. BMJ 310: 170.
14. Andersson T, Alfredsson L, Kallberg H, Zdravkovic S, Ahlbom A, (2005) Calculating measures of biological interaction. Eur J Epidemiol 20: 575-579.
15. Li R, Chambless L, (2007) Test for additive interaction in proportional hazards models. Ann Epidemiol 17: 227-236.
16. Gail M, Brinton L, Byar D, Corle D, Green S, et al. (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81: 1879-1886.
17. Wood AM, White I, Thompson SG, Lewington S, Danesh J, (2006) Regression dilution methods for meta-analysis: assessing long-term variability in plasma fibrinogen among 27,247 adults in 15 prospective studies. Int J Epidemiol 35: 1570-1578.
18. Clarke R, Shipley M, Lewington S, Youngman L, Collins R, et al. (1999) Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol 150: 341-353.
19. Emberson JR, Whincup PH, Morris RW, Walker M, Lowe GD, et al. (2004) Extent of regression dilution for established and novel coronary risk factors: results from the British Regional Heart Study. Eur J Cardiovasc Prev Rehabil 11: 125-134.
20. Whitlock G, Clark T, Vander Hoorn S, Rodgers A, Jackson R, et al. (2001) Random errors in the measurement of 10 cardiovascular risk factors. Eur J Epidemiol 17: 907-909.
21. Collaboration FS, (2009) Correcting for multivariate measurement error by regression calibration in meta-analyses of epidemiological studies. Stat Med 28: 1067-1092.
22. Sandblom G, Dufmats M, Olsson M, Varenhorst E, (2003) Validity of a population-based cancer register in Sweden an assessment of data reproducibility in the South-East region prostate cancer register. Scand J Urol Nephrol 37: 112-119.
23. Larsen I, Småstuen M, Johannesen T, Langmark F, Parkin D, et al. (2008) Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness. Eur J Cancer 45: 1218-31.
24. Rapp K, Schroeder J, Klenk J, Ulmer H, Concin H, et al. (2006) Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia 49: 945-952.
25. Ildaphonse G, George PS, Mathew A, (2009) Obesity and kidney cancer risk in men: a meta-analysis (1992-2008). Asian Pac J Cancer Prev 10: 279-286.
26. Flaherty K, Fuchs C, Colditz G, Stampfer M, Speizer F, et al. (2005) A prospective study of body mass index, hypertension, and smoking and the risk of renal cell carcinoma (United States). Cancer Causes Control 16: 1099-1106.
27. Setiawan V, Stram D, Nomura A, Kolonel L, Henderson B, (2007) Risk Factors for Renal Cell Cancer: The Multiethnic Cohort. Am J Epidemiol 166: 932.
28. Weikert S, Boeing H, Pischon T, Weikert C, Olsen A, et al. (2007) Blood pressure and risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition. Am J Epidemiol 167: 438-46.
29. Bjorge T, Tretli S, Engeland A, (2004) Relation of height and body mass index to renal cell carcinoma in two million Norwegian men and women. Am J Epidemiol 160: 1168-1176.
30. Mathew A, George PS, Ildaphonse G, (2009) Obesity and kidney cancer risk in women: a meta-analysis (1992-2008). Asian Pac J Cancer Prev 10: 471-478.
31. Nicodemus K, Sweeney C, Folsom A, (2004) Evaluation of dietary, medical and lifestyle risk factors for incident kidney cancer in postmenopausal women. Int J Cancer 108: 115-21.
32. Lindblad P, Chow W, Chan J, Bergström A, Wolk A, et al. (1999) The role of diabetes mellitus in the aetiology of renal cell cancer. Diabetologia 42: 107-112.
33. Adams K, Leitzmann M, Albanes D, Kipnis V, Moore S, et al. (2008) Body size and renal cell cancer incidence in a large US cohort study. Am J Epidemiol 168: 268-77.
34. Brock K, Gridley G, Lynch C, Ershow A, Cantor K, (2007) Obesity and hypertension interact to increase risk of renal cell carcinoma in Iowa, USA. Obes Res Clin Pract 1: 147-153.
35. Hunt J, Van der Hel O, McMillan G, Boffetta P, Brennan P, (2005) Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies. Int J Cancer 114: 101-8.
36. Calle E, Kaaks R, (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4: 579-591.
37. Gago-Dominguez M, Castelao J, Yuan J, Ross R, Yu M, (2002) Lipid peroxidation: a novel and unifying concept of the etiology of renal cell carcinoma (United States). Cancer Causes Control 13: 287-293.
38. Lipworth L, Tarone R, McLaughlin J, (2006) The epidemiology of renal cell carcinoma. J Urol 176: 2353-2358.